Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia.

dc.contributor.authorColijn, Johanna M
dc.contributor.authorden Hollander, Anneke I
dc.contributor.authorDemirkan, Ayse
dc.contributor.authorCougnard-Grégoire, Audrey
dc.contributor.authorVerzijden, Timo
dc.contributor.authorKersten, Eveline
dc.contributor.authorMeester-Smoor, Magda A
dc.contributor.authorMerle, Benedicte M J
dc.contributor.authorPapageorgiou, Grigorios
dc.contributor.authorAhmad, Shahzad
dc.contributor.authorMulder, Monique T
dc.contributor.authorCosta, Miguel Angelo
dc.contributor.authorBenlian, Pascale
dc.contributor.authorBertelsen, Geir
dc.contributor.authorBron, Alain M
dc.contributor.authorClaes, Birte
dc.contributor.authorCreuzot-Garcher, Catherine
dc.contributor.authorErke, Maja Gran
dc.contributor.authorFauser, Sascha
dc.contributor.authorFoster, Paul J
dc.contributor.authorHammond, Christopher J
dc.contributor.authorHense, Hans-Werner
dc.contributor.authorHoyng, Carel B
dc.contributor.authorKhawaja, Anthony P
dc.contributor.authorKorobelnik, Jean-Francois
dc.contributor.authorPiermarocchi, Stefano
dc.contributor.authorSegato, Tatiana
dc.contributor.authorSilva, Rufino
dc.contributor.authorSouied, Eric H
dc.contributor.authorWilliams, Katie M
dc.contributor.authorvan Duijn, Cornelia M
dc.contributor.authorDelcourt, Cécile
dc.contributor.authorKlaver, Caroline C W
dc.contributor.authorEuropean Eye Epidemiology Consortium
dc.contributor.authorEYE-RISK Consortium
dc.date.accessioned2025-01-07T17:24:15Z
dc.date.available2025-01-07T17:24:15Z
dc.date.issued2018-10-10
dc.description.abstractGenetic and epidemiologic studies have shown that lipid genes and high-density lipoproteins (HDLs) are implicated in age-related macular degeneration (AMD). We studied circulating lipid levels in relationship to AMD in a large European dataset. Pooled analysis of cross-sectional data. Individuals (N = 30 953) aged 50 years or older participating in the European Eye Epidemiology (E3) consortium and 1530 individuals from the Rotterdam Study with lipid subfraction data. AMD features were graded on fundus photographs using the Rotterdam classification. Routine blood lipid measurements, genetics, medication, and potential confounders were extracted from the E3 database. In a subgroup of the Rotterdam Study, lipid subfractions were identified by the Nightingale biomarker platform. Random-intercepts mixed-effects models incorporating confounders and study site as a random effect were used to estimate associations. AMD features and stage; lipid measurements. HDL was associated with an increased risk of AMD (odds ratio [OR], 1.21 per 1-mmol/l increase; 95% confidence interval [CI], 1.14-1.29), whereas triglycerides were associated with a decreased risk (OR, 0.94 per 1-mmol/l increase; 95% CI, 0.91-0.97). Both were associated with drusen size. Higher HDL raised the odds of larger drusen, whereas higher triglycerides decreases the odds. LDL cholesterol reached statistical significance only in the association with early AMD (P = 0.045). Regarding lipid subfractions, the concentration of extra-large HDL particles showed the most prominent association with AMD (OR, 1.24; 95% CI, 1.10-1.40). The cholesteryl ester transfer protein risk variant (rs17231506) for AMD was in line with increased HDL levels (P = 7.7 × 10-7), but lipase C risk variants (rs2043085, rs2070895) were associated in an opposite way (P = 1.0 × 10-6 and P = 1.6 × 10-4). Our study suggested that HDL cholesterol is associated with increased risk of AMD and that triglycerides are negatively associated. Both show the strongest association with early AMD and drusen. Extra-large HDL subfractions seem to be drivers in the relationship with AMD, and variants in lipid genes play a more ambiguous role in this association. Whether systemic lipids directly influence AMD or represent lipid metabolism in the retina remains to be answered.
dc.identifier.doi10.1016/j.ophtha.2018.09.045
dc.identifier.essn1549-4713
dc.identifier.pmid30315903
dc.identifier.unpaywallURLhttps://cris.maastrichtuniversity.nl/files/75103063/Berendschot_2019_Increased_High_Density_Lipoprotein_Levels.pdf
dc.identifier.urihttps://hdl.handle.net/10668/28357
dc.issue.number3
dc.journal.titleOphthalmology
dc.journal.titleabbreviationOphthalmology
dc.language.isoen
dc.organizationCentro Andaluz de Biología Molecular (CABIMER)
dc.page.number393-406
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshCholesterol Ester Transfer Proteins
dc.subject.meshCholesterol, HDL
dc.subject.meshCholesterol, LDL
dc.subject.meshCross-Sectional Studies
dc.subject.meshEuropean Union
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLipid Metabolism
dc.subject.meshMacular Degeneration
dc.subject.meshMagnetic Resonance Spectroscopy
dc.subject.meshMale
dc.subject.meshMetabolomics
dc.subject.meshMiddle Aged
dc.subject.meshOdds Ratio
dc.subject.meshPolymorphism, Single Nucleotide
dc.subject.meshRisk Factors
dc.subject.meshTriglycerides
dc.subject.meshWhite People
dc.titleIncreased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number126

Files